Innovative Medicines Initiative (IMI) approves € 40 million project for better care of patients with haematologic malignancies
Brussels/Salamanca, January 9, 2017. The Innovative Medicines Initiative (IMI) has approved HARMONY, a project that aims to foster better access and care for patients with various hematologic malignancies (HM) with the use of big data. The project is made up of 51 partners from 11 European countries, including 7 pharmaceutical companies. Other organisations such as Myeloma Patients Europe (MPE), Lynphoma Coalition, MSD Alliance or CLL Advocate will be involved in this project as well in…